HomeRamiprilRamipril + Triamterene

Does Ramipril Interact with Triamterene?

Ramipril and Triamterene have a major drug interaction according to U.S. FDA drug labeling data. Potassium-sparing diuretic increases risk of hyperkalemia. Frequent monitoring of serum potassium recommended if concomitant use indicated. The mechanism involves increased risk of hyperkalemia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Ramipril Class
Angiotensin Converting Enzyme Inhibitor
Triamterene Class
Potassium-sparing Diuretic
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ramipril and Triamterene occurs because increased risk of hyperkalemia. Clinically, this means potassium-sparing diuretic increases risk of hyperkalemia. frequent monitoring of serum potassium recommended if concomitant use indicated. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Ramipril and your doctor is considering prescribing Triamterene (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ramipril(Altace)+💊 Triamterene(Triamterene)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin Converting Enzyme Inhibitor
Drug B class
Potassium-sparing Diuretic
Source
NLP:ramipril

What this means in plain English

Potassium-sparing diuretic increases risk of hyperkalemia. Frequent monitoring of serum potassium recommended if concomitant use indicated.

About Ramipril and Triamterene

Ramipril is an Angiotensin Converting Enzyme Inhibitor, while Triamterene is a Potassium-sparing Diuretic. Ramipril is also sold under the brand name Altace. Both medications are taken by mouth. Both Ramipril and Triamterene carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Increased risk of hyperkalemia"

📖 Source: NLP:ramipril

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ramipril and Triamterene against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.